Gold Standard Diagnostics

Company

Gold Standard Diagnostics is a pioneer in providing products, services and consulting to the diagnostic and medical communities. We partner with reagent and equipment manufacturers from around the world, creating innovative and cost effective diagnostics solutions for clinical and hospital laboratories. Gold Standard also develops our own suite of proprietary products that provide our customers the next wave of technology-based solutions. Our solutions enable customers to provide more effective, better quality health care to their patients.

What We Do

GSD provides a wide range of services to our manufacturing partners and laboratory customers.

For our manufacturing partners, our primary focus is on marketing, selling, and supporting their products throughout the United States. We provide expert market analysis and technical consultation in the design and development of new products. Additionally, we provide guidance and assistance in the review and approval of new products by regulatory agencies, and we monitor the feedback regarding the deployment and practical application of their products in clinical laboratories.

For our laboratory customers, our primary focus is on timely and effective installation of diagnostic technologies that best meet their specific business needs. We also provide expert on-site technical assistance to deal with any operational issues that may arise in the use of those technologies. Additionally, our team consults our laboratory customers in the selection of specific diagnostic technologies and products appropriate to laboratory needs, and serve as ongoing liaison with manufacturing partners regarding delivery schedules and product updates.

What's New

Neovacs SA And Biomedical Diagnostics (GBI) Announce OSEO Innovation Grant Of EUR 7.9 Million For Theranostics Project In Rheumatoid Arthritis.

Paris, October 2, 2008 - Neovacs (www.neovacs.com), a leading biotechnology company in the development of anticytokine and anti-protein viral regulation therapeutic vaccines to treat certain cancers and inflammatory diseases, and Biomedical Diagnostics (www.bmd-net.com), a diagnostic company specializing in auto-immune diseases, today announced that they have received a €7.9 million grant from OSEO Innovation to support “Tracker”, a theranostics project concerning rheumatoid arthritis.

Read more... Link  

Exclusive Partners